A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 2,606,124 shares of ABBV stock, worth $469 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
2,606,124
Previous 2,415,668 7.88%
Holding current value
$469 Million
Previous $414 Million 24.21%
% of portfolio
0.56%
Previous 0.51%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$163.84 - $199.33 $31.2 Million - $38 Million
190,456 Added 7.88%
2,606,124 $515 Million
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $40.1 Million - $46.9 Million
259,262 Added 12.02%
2,415,668 $414 Million
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $49.8 Million - $56.8 Million
311,771 Added 16.9%
2,156,406 $393 Million
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $14.8 Million - $16.6 Million
107,240 Added 6.17%
1,844,635 $286 Million
Q3 2023

Nov 07, 2023

BUY
$133.59 - $154.65 $17.7 Million - $20.5 Million
132,506 Added 8.26%
1,737,395 $259 Million
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $10.2 Million - $12.7 Million
76,722 Added 5.02%
1,604,889 $216 Million
Q1 2023

May 08, 2023

BUY
$144.61 - $166.54 $20.3 Million - $23.4 Million
140,229 Added 10.1%
1,528,167 $244 Million
Q4 2022

Feb 07, 2023

BUY
$138.31 - $165.87 $20.9 Million - $25.1 Million
151,274 Added 12.23%
1,387,938 $224 Million
Q3 2022

Nov 01, 2022

BUY
$134.21 - $153.93 $17.7 Million - $20.3 Million
131,673 Added 11.92%
1,236,664 $166 Million
Q2 2022

Aug 04, 2022

BUY
$137.62 - $174.96 $10.7 Million - $13.6 Million
77,804 Added 7.57%
1,104,991 $169 Million
Q1 2022

May 09, 2022

BUY
$131.98 - $163.75 $9.09 Million - $11.3 Million
68,904 Added 7.19%
1,027,187 $167 Million
Q4 2021

Feb 07, 2022

BUY
$107.43 - $135.93 $12 Million - $15.1 Million
111,318 Added 13.14%
958,283 $130 Million
Q3 2021

Nov 04, 2021

BUY
$106.4 - $120.78 $8.13 Million - $9.23 Million
76,434 Added 9.92%
846,965 $91.4 Million
Q2 2021

Aug 06, 2021

BUY
$105.21 - $117.21 $5.8 Million - $6.46 Million
55,120 Added 7.7%
770,531 $86.8 Million
Q1 2021

May 06, 2021

BUY
$102.3 - $112.62 $3.6 Million - $3.97 Million
35,222 Added 5.18%
715,411 $77.4 Million
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $4.7 Million - $6.35 Million
58,396 Added 9.39%
680,189 $72.9 Million
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $8.24 Million - $9.67 Million
95,925 Added 18.24%
621,793 $54.5 Million
Q2 2020

Aug 06, 2020

BUY
$73.37 - $98.18 $7.74 Million - $10.4 Million
105,529 Added 25.11%
525,868 $51.6 Million
Q1 2020

May 11, 2020

BUY
$64.5 - $97.79 $4.78 Million - $7.24 Million
74,043 Added 21.38%
420,339 $32 Million
Q4 2019

Feb 05, 2020

BUY
$72.13 - $90.25 $5.76 Million - $7.2 Million
79,790 Added 29.94%
346,296 $30.7 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $649,071 - $780,370
10,306 Added 4.02%
266,506 $20.2 Million
Q2 2019

Aug 08, 2019

BUY
$65.7 - $83.98 $3 Million - $3.84 Million
45,695 Added 21.71%
256,200 $18.6 Million
Q1 2019

Apr 26, 2019

BUY
$77.14 - $90.79 $687,085 - $808,666
8,907 Added 4.42%
210,505 $17 Million
Q4 2018

Feb 08, 2019

SELL
$77.85 - $96.01 $950,704 - $1.17 Million
-12,212 Reduced 5.71%
201,598 $17.4 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $391,292 - $434,994
-4,401 Reduced 2.02%
213,810 $20.2 Million
Q2 2018

Aug 09, 2018

SELL
$89.78 - $106.23 $952,116 - $1.13 Million
-10,605 Reduced 4.63%
218,211 $20.2 Million
Q1 2018

May 02, 2018

SELL
$92.01 - $123.21 $2.09 Million - $2.8 Million
-22,737 Reduced 9.04%
228,816 $21.7 Million
Q4 2017

Feb 06, 2018

BUY
$89.56 - $98.21 $16,210 - $17,776
181 Added 0.07%
251,553 $25.1 Million
Q3 2017

Nov 01, 2017

BUY
$69.85 - $89.22 $17.6 Million - $22.4 Million
251,372
251,372 $22.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.